Lingua Tech Singapore (LTS) awarded 2 years contract with GlaxoSmithKline (GSK)
1 June 2007
Singapore - June 01, 2007 - Lingua Tech Singapore (LTS), a premier Localization Solutions Provider, announced today that it has been awarded a 2-year contract by GlaxoSmithKline Pte Ltd (GSK) to provide localization solution.
Under the contract, LTS will provide GSK with localization and translation of all documents including Clinical Trial Materials, Research Reports, Datasheets, Labels, Marketing Materials etc. Lingua Tech will also provide design/desktop publishing and printing services to offer GSK a complete turnkey localization solution.
LTS has been providing localization services to GSK since 2000. LTS regards this contract as an endorsement from one of its most valued customers and LTS looks forward to strengthening the relationship and contributing towards the success of GSK's localization efforts in this region.
About GSK
GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies. Headquartered in the UK and with worldwide operations, GSK is one of the industry leaders, with an estimated seven per cent of the world's pharmaceutical market. GSK is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. For more information, please visit: http://www.gsk.com
About Lingua Tech Singapore
Established in 1996, Lingua Tech is one of the pioneers in translation/localization in Singapore. Today, it is the leading language service company and is one of the most successful ones in Singapore. The company offers turn-key localization solutions to both local and foreign government agencies, Fortune 500 companies as well as high-growth SMEs in the region and worldwide. For more information, please visit: http://www.linguasg.com
